Anokye R., Acheampong E., Budu-Ainooson A., Obeng E.I., Akwasi A.G. Prevalence of postpartum depression and interventions utilized for its management. Ann Gen Psychiatry. 2018;17:18. doi: 10.1186/s12991-018-0188-0..
DOI: 10.1186/s12991-018-0188-0
Franca U.L., McManus M. Frequency, trends, and antecedents of severe maternal depression after three million U.S. births. PLoS One. 2018;13(2):e0192854. doi: 10.1371/journal.pone.0192854..
DOI: 10.1371/journal.pone.0192854
Резник В.А., Козырко Е.В., Рязанова О.В., Александрович Ю.С., Рухляда Н.Н., Тапильская Н.И. Распространенность и лабораторные маркеры послеродовой депрессии. Журнал акушерства и женских болезней. 2018;67(4):19–29. doi: 10.17816/JOWD67419-29..
DOI: 10.17816/JOWD67419-29
Корнетов Н.А. Послеродовая депрессия – центральная проблема охраны психического здоровья раннего материнства. Бюллетень сибирской медицины. 2015;14(6):5–24. doi: 10.20538/1682-0363-2015-6-5-24..
DOI: 10.20538/1682-0363-2015-6-5-24
Fiala A., Švancara J., Klánová J., Kašpárek T. Sociodemographic and delivery risk factors for developing postpartum depression in a sample of 3233 mothers from the Czech ELSPAC study. BMC Psychiatry. 2017;17:104. doi: 10.1186/s12888-017-1261-y..
DOI: 10.1186/s12888-017-1261-y
Mbarak B., Kilewo C., Kuganda S., Sunguya B.F. Postpartum depression among women with pre-eclampsia and eclampsia in Tanzania; a call for integrative intervention. BMC Pregnancy Childbirth. 2019;19:270. doi: 10.1186/s12884-019-2395-3..
DOI: 10.1186/s12884-019-2395-3
Silverman M.E., Reichenberg A., Lichtenstein P., Sandin S. Is depression more likely following childbirth? A population-based study. Arch Womens Ment Health. 2019;22(2):253–258. doi: 10.1007/s00737-018-0891-5..
DOI: 10.1007/s00737-018-0891-5
Wisner K.L., Sit D.K.Y., McShea M.C., Rizzo D.M., Zoretich R.A., Hughes C.L. et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70(5):490–498. doi: 10.1001/jamapsychiatry.2013.87..
DOI: 10.1001/jamapsychiatry.2013.87
Pataky E.A., Ehlert U. Longitudinal assessment of symptoms of postpartum mood disorder in women with and without a history of depression. Arch Womens Ment Health. 2020;23(3):391–399. doi: 10.1007/s00737-019-00990-4..
DOI: 10.1007/s00737-019-00990-4
Silverman M.E., Reichenberg A., Savitz D.A., Cnattingius S., Lichtenstein P., Hultman C.M. The risk factors for postpartum depression: A populationbased study. Depression and Anxiety. 2017;34(2):178–187. doi: 10.1002/da.22597..
DOI: 10.1002/da.22597
Milgrom J., Gemmill A.W., Bilszta J.L., Hayes B., Barnett B., Brooks J. et al. Antenatal risk factors for postnatal depression: a large prospective study. J Affect Disord. 2008;108(1-2):147–157. doi: 10.1016/j.jad.2007.10.014..
DOI: 10.1016/j.jad.2007.10.014
Yazici E., Kirkan T.S., Aslan P.A., Aydin N., Yazici A.B. Untreated depression in the first trimester of pregnancy leads to postpartum depression: high rates from a natural follow-up study. Neuropsychiatr Dis Treat. 2015;11:405–411. doi: 10.2147/NDT.S77194..
DOI: 10.2147/NDT.S77194
Slomian J., Honvo G., Emonts P., Reginster J.Y., Bruyère O. Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes. Womens Health (Lond). 2019;15:1745506519844044. doi: 10.1177/1745506519844044..
DOI: 10.1177/1745506519844044
Tuovinen S., Lahti-Pulkkinen M., Girchenko P., Lipsanen J., Lahti J., Heinonen K. et al. Maternal depressive symptoms during and after pregnancy and child developmental milestones. Depress Anxiety. 2018;35(8):732–741. doi: 10.1002/da.22756..
DOI: 10.1002/da.22756
Farías-Antúnez S., Xavier M.O., Santos I.S. Effect of maternal postpartum depression on offspring’s growth. J Affect Disord. 2018;228:143–152. doi: 10.1016/j.jad.2017.12.013..
DOI: 10.1016/j.jad.2017.12.013
Aoyagi S.-S., Takei N., Nishimura T., Nomura Y., Tsuchiya K.J. Association of late-onset postpartum depression of mothers with expressive language development during infancy and early childhood: the HBC study. PeerJ. 2019;7:e6566. doi: 10.7717/peerj.6566..
DOI: 10.7717/peerj.6566
Kawai E., Takagai S., Takei N., Itoh H., Kanayama N., Tsuchiya K.J. et al. Maternal postpartum depressive symptoms predict delay in non-verbal communication in 14-month-old infants. Infant Behav Dev. 2017;46:33–45. doi: 10.1016/j.infbeh.2016.11.006..
DOI: 10.1016/j.infbeh.2016.11.006
Vizzini L., Popovic M., Zugna D., Vitiello B., Trevisan M., Pizzi C. et al. Maternal anxiety, depression and sleep disorders before and during pregnancy, and preschool ADHD symptoms in the NINFEA birth cohort study. Epidemiol Psychiatr Sci. 2019;28(5):521–531. doi: 10.1017/S2045796018000185..
DOI: 10.1017/S2045796018000185
Kingston D., Kehler H., Austin M.-P., Mughal M.K., Wajid A., Vermeyden L. et al. Trajectories of maternal depressive symptoms during pregnancy and the first 12 months postpartum and child externalizing and internalizing behavior at three years. PLoS One. 2018;13(4):e0195365. doi: 10.1371/journal.pone.0195365..
DOI: 10.1371/journal.pone.0195365
Sharma V., Doobay M. Bipolar postpartum depression: An update and recommendations. J Affect Disord. 2017;219:105–111. doi: 10.1016/j.jad.2017.05.014..
DOI: 10.1016/j.jad.2017.05.014
Казаковцев Б.А., Голланд В.Б. (ред.) Психические расстройства и расстройства поведения (F00F99) (Класс V МКБ10, адаптированный для использования в Российской Федерации). М.: Минздрав России; 1998. 512 с. Режим доступа: https://psychiatr.ru/download/1998?view=1&name=[%]D0[%]9C[%]D0[%]9A[%]D0[%]91-10_[%]D1[%]81_[%]D0[%]B3[%]D0[%]B8[%]D0[%]BF[%]D0[%]B5[%]D1[%]80[%]D1[%]81[%]D1[%]81[%]D1[%]8B[%]D0[%]BB[%]D0[%]BA[%]D0[%]B0[%]D0[%]BC[%]D0[%]B8.pdf.https://psychiatr.ru/download/1998?view=1&name=[%]D0[%]9C[%]D0[%]9A[%]D0[%]91-10_[%]D1[%]81_[%]D0[%]B3[%]D0[%]B8[%]D0[%]BF[%]D0[%]B5[%]D1[%]80[%]D1[%]81[%]D1[%]81[%]D1[%]8B[%]D0[%]BB[%]D0[%]BA[%]D0[%]B0[%]D0[%]BC[%]D0[%]B8.pdf
Казаковцев Б.А., Голланд В.Б. (ред.) Психические расстройства и расстройства поведения (F00F99) (Класс V МКБ10, адаптированный для использования в Российской Федерации). М.: Минздрав России; 1998. 512 с. Режим доступа: https://psychiatr.ru/download/1998?view=1&name=[%]D0[%]9C[%]D0[%]9A[%]D0[%]91-10_[%]D1[%]81_[%]D0[%]B3[%]D0[%]B8[%]D0[%]BF[%]D0[%]B5[%]D1[%]80[%]D1[%]81[%]D1[%]81[%]D1[%]8B[%]D0[%]BB[%]D0[%]BA[%]D0[%]B0[%]D0[%]BC[%]D0[%]B8.pdf.https://psychiatr.ru/download/1998?view=1&name=[%]D0[%]9C[%]D0[%]9A[%]D0[%]91-10_[%]D1[%]81_[%]D0[%]B3[%]D0[%]B8[%]D0[%]BF[%]D0[%]B5[%]D1[%]80[%]D1[%]81[%]D1[%]81[%]D1[%]8B[%]D0[%]BB[%]D0[%]BA[%]D0[%]B0[%]D0[%]BC[%]D0[%]B8.pdf
Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013. doi: 10.1176/appi.books.9780890425596..
DOI: 10.1176/appi.books.9780890425596
Forty L., Jones L., Macgregor S., Caesar S., Cooper C., Hough A. et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry. 2006;163(9):1549–1553. doi: 10.1176/ajp.2006.163.9.1549..
DOI: 10.1176/ajp.2006.163.9.1549
Stewart D.E., Vigod S. Postpartum Depression. N Engl J Med. 2016;375(22):2177–2186. doi: 10.1056/NEJMcp1607649..
DOI: 10.1056/NEJMcp1607649
Kozinszky Z., Dudas R.B. Validation studies of the Edinburgh Postnatal Depression Scale for the antenatal period. J Affect Disord. 2015;176:95– 105. doi: 10.1016/j.jad.2015.01.044..
DOI: 10.1016/j.jad.2015.01.044
Fox M., Sandman C.A., Davis E.P., Glynn L.M. A longitudinal study of women’s depression symptom profiles during and after the postpartum phase. Depress Anxiety. 2018;35(4):292–304. doi: 10.1002/da.22719..
DOI: 10.1002/da.22719
Hoertel N., López S., Peyre H., Wall M.M., González-Pinto A., Limosin F., Blanco C. Are symptom features of depression during pregnancy, the postpartum period and outside the peripartum period distinct? Results from a nationally representative sample using item response theory (IRT). Depress Anxiety. 2015;32(2):129–140. doi: 10.1002/da.22334..
DOI: 10.1002/da.22334
Голенков А.В., Филоненко В.А., Филоненко А.В. Расстройства сна как один из показателей послеродовой депрессии. Журнал неврологии и психиатрии. 2019;119(4-2):81–88. doi: 10.17116/jnevro201911904281..
DOI: 10.17116/jnevro201911904281
Sockol L.E. A systematic review and meta-analysis of interpersonal psychotherapy for perinatal women. J Affect Disord. 2018;232:316–328. doi: 10.1016/j.jad.2018.01.018..
DOI: 10.1016/j.jad.2018.01.018
Nillni Y.I., Mehralizade A., Mayer L., Milanovic S. Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: A systematic review. Clin Psychol Rev. 2018;66:136–148. doi: 10.1016/j.cpr.2018.06.004..
DOI: 10.1016/j.cpr.2018.06.004
Payne J.L. Psychopharmacology in Pregnancy and Breastfeeding. Med Clin North Am. 2019;103(4):629–650. doi: 10.1016/j.mcna.2019.02.009..
DOI: 10.1016/j.mcna.2019.02.009
Tracy T.S., Venkataramanan R., Glover D.D., Caritis S.N. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol. 2005;192(2):633–639. doi: 10.1016/j. ajog.2004.08.030..
DOI: 10.1016/j. ajog.2004.08.030
Tracy T.S., Venkataramanan R., Glover D.D., Caritis S.N. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol. 2005;192(2):633–639. doi: 10.1016/j. ajog.2004.08.030..
DOI: 10.1016/j.ajog.2004.08.030
Hantsoo L., Ward-O’Brien D., Czarkowski K.A., Gueorguieva R., Price L.H., Epperson C.N. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology. 2014;231(5):939– 948. doi: 10.1007/s00213-013-3316-1..
DOI: 10.1007/s00213-013-3316-1
Misri S., Abizadeh J., Albert G., Carter D., Ryan D. Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram. J Clin Psychopharmacol. 2012;32(5):729–732. doi: 10.1097/JCP.0b013e31826867c9..
DOI: 10.1097/JCP.0b013e31826867c9
Roy A., Cole K., Goldman Z., Barris M. Fluoxetine treatment of postpartum depression. Am J Psychiatry. 1993;150(8):1273a–1273. doi: 10.1176/ajp.150.8.1273a..
DOI: 10.1176/ajp.150.8.1273a
Cohen L.S., Viguera A.C., Bouffard S.M., Nonacs R.M., Morabito C., Collins M.H., Ablon J.S. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry. 2001;62(8):592–596. doi: 10.4088/jcp.v62n0803..
DOI: 10.4088/jcp.v62n0803
Nonacs R.M., Soares C.N., Viguera A.C., Pearson K., Poitras J.R., Cohen L.S. Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol. 2005;8(3):445–449. doi: 10.1017/S1461145705005079..
DOI: 10.1017/S1461145705005079
Sharma V., Sommerdyk C. Are antidepressants effective in the treatment of postpartum depression? A systematic review. Prim Care Companion CNS Disord. 2013;15(6):PCC.13r01529. doi: 10.4088/PCC.13r01529..
DOI: 10.4088/PCC.13r01529
De Crescenzo F., Perelli F., Armando M., Vicari S. Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials. J Affect Disord. 2014;152–154:39–44. doi: 10.1016/j.jad.2013.09.019..
DOI: 10.1016/j.jad.2013.09.019
Molyneaux E., Howard L.M., McGeown H.R., Karia A.M., Trevillion K. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2014;(9):CD002018. doi: 10.1002/14651858.CD002018.pub2..
DOI: 10.1002/14651858.CD002018.pub2
Uguz F. Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety. J Clin Psychopharmacol. 2016;36(3):244–252. doi: 10.1097/JCP.0000000000000491..
DOI: 10.1097/JCP.0000000000000491
Orsolini L., Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol. 2015;30(1):4–20. doi: 10.1002/hup.2451..
DOI: 10.1002/hup.2451
Kronenfeld N., Berlin M., Shaniv D., Berkovitch M. Use of Psychotropic Medications in Breastfeeding Women. Birth Defects Res. 2017;109(12):957–997. doi: 10.1002/bdr2.1077..
DOI: 10.1002/bdr2.1077
Marshall A.M., Hernandez L.L., Horseman N.D. Serotonin and serotonin transport in the regulation of lactation. J Mammary Gland Biol Neoplasia. 2014;19(1):139–146. doi: 10.1007/s10911-013-9304-6..
DOI: 10.1007/s10911-013-9304-6
Holland D. An observation of the effect of sertraline on breast milk supply. Aust N Z J Psychiatry. 2000;34(6):1032. doi: 10.1080/000486700283..
DOI: 10.1080/000486700283
Cuomo A., Maina G., Neal S.M., De Montis G., Rosso G., Scheggi S. et al. Using sertraline in postpartum and breastfeeding: balancing risks and benefits. Exp Opin Drug Saf. 2018;17(7):719–725. doi: 10.1080/14740338.2018.1491546..
DOI: 10.1080/14740338.2018.1491546
Pinheiro E., Bogen D.L., Hoxha D., Ciolino J.D., Wisner K.L. Sertraline and breastfeeding: review and meta-analysis. Arch Womens Ment Health. 2015;18(2):139–146. doi: 10.1007/s00737-015-0499-y..
DOI: 10.1007/s00737-015-0499-y
McAllister-Williams R.H., Baldwin D.S., Cantwell R., Easter A., Gilvarry E., Glove V. et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum. J Psychopharmacol. 2017;31(5):519–552. doi: 10.1177/0269881117699361..
DOI: 10.1177/0269881117699361
Uguz F., Arpaci N. Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital. Breastfeed Med. 2016;11(9):487–489. doi: 10.1089/bfm.2016.0095..
DOI: 10.1089/bfm.2016.0095
Gentile S. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf. 2007;30(2):107–121. doi: 10.2165/00002018-200730020-00002..
DOI: 10.2165/00002018-200730020-00002
Smit M., Dolman K.M., Honig A. Mirtazapine in pregnancy and lactation – a systematic review. Eur Neuropsychopharmacol. 2016;26(1):126–135. doi: 10.1016/j.euroneuro.2015.06.014..
DOI: 10.1016/j.euroneuro.2015.06.014
Bellantuono C., Vargas M., Mandarelli G., Nardi B., Martini M.G. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review. Hum Psychopharmacol. 2015;30(3):143–151. doi: 10.1002/hup.2473..
DOI: 10.1002/hup.2473
Sriraman N.K., Melvin K., Meltzer-Brody S. ABM clinical protocol #18: use of antidepressants in breastfeeding mothers. Breastfeed Med. 2015;10(6):290–299. doi: 10.1089/bfm.2015.29002..
DOI: 10.1089/bfm.2015.29002
Shyken J.M., Babbar S., Babbar S., Forinash A. Benzodiazepines in Pregnancy. Clin Obstet Gynecol. 2019;62(1):156–167. doi: 10.1097/GRF.0000000000000417..
DOI: 10.1097/GRF.0000000000000417
Sharma V., Sommerdyk C., Xie B. Aripiprazole augmentation of antidepressants for postpartum depression: a preliminary report. Arch Womens Ment Health. 2015;18(1):131–134. doi: 10.1007/s00737-014-0462-3..
DOI: 10.1007/s00737-014-0462-3
Yazdani-Brojeni P., Tanoshima R., Taguchi N., Garcia-Bournissen F., Wallach I., Moretti M.E. et al. Quetiapine Excretion Into Human Breast Milk. J Clin Psychopharmacol. 2018;38(4):362–364. doi: 10.1097/JCP.0000000000000905..
DOI: 10.1097/JCP.0000000000000905
Misri S., Corral M., Wardrop A.A., Kendrick K. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol. 2006;26(5):508– 511. doi: 10.1097/01.jcp.0000236656.70544.f3..
DOI: 10.1097/01.jcp.0000236656.70544.f3
Aydin B., Nayir T., Sahin S., Yildiz A. Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy. J Clin Psychopharmacol. 2015;35(2):206–208. doi: 10.1097/JCP.0000000000000291..
DOI: 10.1097/JCP.0000000000000291
Sharma V., Khan M., Sommerdyk C. Quetiapine in the Acute Treatment of Bipolar Postpartum Depression: A Chart Review. J Clin Psychopharmacol. 2015;35(6):733–735. doi: 10.1097/JCP.0000000000000415..
DOI: 10.1097/JCP.0000000000000415
Misri S., Abizadeh J., Eng A.B., Albert G., Ryan D., Swift E. An Open-Label Study of Quetiapine Extended-Release in a Sample of Postpartum Women with Bipolar II Depressive Episode. Curr Psychopharmacol. 2015;4(1):17–26. doi: 10.2174/2211556004666150604235028..
DOI: 10.2174/2211556004666150604235028
Birnbaum A.K., Meador K.J., Karanam A., Brown C., May R.C., Gerard E.E. et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. JAMA Neurol. 2020;77(4):441–450. doi: 10.1001/jamaneurol.2019.4443..
DOI: 10.1001/jamaneurol.2019.4443
Bar-Oz B., Nulman I., Koren G., Ito S. Anticonvulsants and breastfeeding: A critical review. Paediatr Drugs. 2000;2:113–126. doi: 10.2165/00148581-200002020-00004..
DOI: 10.2165/00148581-200002020-00004
Newport D.J., Pennell P.B., Calamaras M.R., Ritchie J.C., Newman M., Knight B. et al. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics. 2008;122(1):e223–e231. doi: 10.1542/peds.2007-3812..
DOI: 10.1542/peds.2007-3812
Miyagi S.J., Collier A.C. Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab Dispos. 2007;35(9):1587–1592. doi: 10.1124/dmd.107.015214..
DOI: 10.1124/dmd.107.015214
Veiby G., Engelsen B.A., Gilhus N.E. Early Child Development and Exposure to Antiepileptic Drugs Prenatally and Through Breastfeeding: A Prospective Cohort Study on Children of Women With Epilepsy. JAMA Neurol. 2013;70(11):1367–1374. doi: 10.1001/jamaneurol.2013.4290..
DOI: 10.1001/jamaneurol.2013.4290
Meador K.J., Baker G.A., Browning N., Cohen M.J., Bromley R.L., ClaytonSmith J. et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168(8):729– 736. doi: 10.1001/jamapediatrics.2014.118..
DOI: 10.1001/jamapediatrics.2014.118
Viguera A.C., Newport D.J., Ritchie J., Stowe Z., Whitfield T., Mogielnicki J. et al. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007;164(2):342–345. doi: 10.1176/ajp.2007.164.2.342..
DOI: 10.1176/ajp.2007.164.2.342
Frew J.R. Psychopharmacology of bipolar I disorder during lactation: a case report of the use of lithium and aripiprazole in a nursing mother. Arch Womens Ment Health. 2015;18(1):135–136. doi: 10.1007/s00737-014-0469-9..
DOI: 10.1007/s00737-014-0469-9
Galbally M., Bergink V., Vigod S.N., Buist A., Boyce P., Chandra P. et al. Breastfeeding and lithium: is breast always best? Lancet Psychiatry. 2018;5(7):534–536. doi: 10.1016/S2215-0366(18)30085-3..
DOI: 10.1016/S2215-0366(18)30085-3
Khan S.J., Fersh M.E., Ernst C., Klipstein K., Albertini E.S., Lusskin S. Bipolar Disorder in Pregnancy and Postpartum: Principles of Management. Curr Psychiatry Rep. 2016;18(2):13. doi: 10.1007/s11920-015-0658-x..
DOI: 10.1007/s11920-015-0658-x
Yatham L., Kennedy S., Parikh S.V., Schaffer A., Bond D.J., Frey B.N. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170. doi: 10.1111/bdi.12609..
DOI: 10.1111/bdi.12609
Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res. 1997;52:1–32.
Zorumski C.F., Paul S.M., Izumi Y., Covey D.F., Mennerick S. Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev. 2013;37(1):109–122. doi: 10.1016/j.neubiorev.2012.10.005..
DOI: 10.1016/j.neubiorev.2012.10.005
Reddy D.S. Chapter 8 – Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–137. doi: 10.1016/B978-0-444-53630-3.00008-7..
DOI: 10.1016/B978-0-444-53630-3.00008-7
Schüle C., Nothdurfter C., Rupprecht R. The role of allopregnanolone in depression and anxiety. Prog Neurobiol. 2014;113:79–87. doi: 10.1016/j.pneurobio.2013.09.003..
DOI: 10.1016/j.pneurobio.2013.09.003
Crowley S.K., O’Buckley T.K., Schiller C.E., Stuebe A., Morrow A.L., Girdler S.S. Blunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot study. Psychopharmacology. 2016;233(7):1299–1310. doi: 10.1007/s00213-016-4217-x..
DOI: 10.1007/s00213-016-4217-x
Osborne L.M., Gispen F., Sanyal A., Yenokyan G., Meilman S., Payne J.L. Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study. Psychoneuroendocrinology. 2017;79:116–121. doi: 10.1016/j.psyneuen.2017.02.012..
DOI: 10.1016/j.psyneuen.2017.02.012
Deligiannidis K.M., Kroll-Desrosiers A.R., Mo S., Nguyen H.P., Svenson A., Jaitly N. et al. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology. 2016;70:98–107. doi: 10.1016/j.psyneuen.2016.05.010..
DOI: 10.1016/j.psyneuen.2016.05.010
Hellgren C., Comasco E., Skalkidou A., Sundström-Poromaa I. Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway. Horm Behav. 2017;94:106–113. doi: 10.1016/j.yhbeh.2017.06.008..
DOI: 10.1016/j.yhbeh.2017.06.008
Guintivano J., Sullivan P.F., Stuebe A.M., Penders T., Thorp J., Rubinow D.R. et al. Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women. Psychol Med. 2018;48(7):1190–1200. doi: 10.1017/S0033291717002641..
DOI: 10.1017/S0033291717002641
Hirst J.J., Kelleher M.A., Walker D.W., Palliser H.K. Neuroactive steroids in pregnancy: key regulatory and protective roles in the foetal brain. J Steroid Biochem Mol Biol. 2014;139:144–153. doi: 10.1016/j.jsbmb.2013.04.002..
DOI: 10.1016/j.jsbmb.2013.04.002
Tuem K.B., Atey T.M. Neuroactive Steroids: Receptor Interactions and Responses. Front Neurol. 2017;8:442. doi: 10.3389/fneur.2017.00442..
DOI: 10.3389/fneur.2017.00442
Benasi G., Guidi J., Offidani E., Balon R., Rickels K., Fava G.A. Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review. Psychother Psychosom. 2018;87(2):65–74. doi: 10.1159/000486696..
DOI: 10.1159/000486696
Botella G.M., Salitur F.G., Harrison B.L., Beresis R.T., Bai Z., Blanco M.-J. et al. Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1’- yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor. J Med Chem. 2017;60(18):7810–7819. doi: 10.1021/acs.jmedchem.7b00846..
DOI: 10.1021/acs.jmedchem.7b00846
Jacob T.C., Michels G., Silayeva L., Haydon J., Succol F., Moss S.J. Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition. Proc Natl Acad Sci USA. 2012;109(45):18595–18600. doi: 10.1073/pnas.1204994109..
DOI: 10.1073/pnas.1204994109
Modgil A., Parakala M.L., Ackley M.A., Doherty J.J., Moss S.J., Davies P.A. Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism. Neuropharmacology. 2017;113(Pt A):314–322. doi: 10.1016/j.neuropharm.2016.10.010..
DOI: 10.1016/j.neuropharm.2016.10.010
Bains J.S., Wamsteeker C., Inoue W. Stress-related synaptic plasticity in the hypothalamus. Nat Rev Neurosci. 2015;16(7):377–388. doi: 10.1038/nrn3881..
DOI: 10.1038/nrn3881
Hewitt S.A., Wamsteeker J.I., Kurz E.U., Bains J.S. Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis. Nat Neurosci. 2009;12(4):438–443. doi: 10.1038/nn.2274..
DOI: 10.1038/nn.2274
Lüscher B., Möhler H. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience. F1000Res. 2019;8:F1000 Faculty Rev-751. doi: 10.12688/f1000research.18758.1..
DOI: 10.12688/f1000research.18758.1
Crowley S.K., Girdler S.S. Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans? Psychopharmacology (Berl.). 2014;231(17):3619–3634. doi: 10.1007/s00213-014-3572-8..
DOI: 10.1007/s00213-014-3572-8
Yim I.S., Tanner Stapleton L.R., Guardino C.M., Hahn-Holbrook J., Dunkel Schetter C. Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. Annu Rev Clin Psychol. 2015;11:99–137. doi: 10.1146/annurev-clinpsy-101414-020426..
DOI: 10.1146/annurev-clinpsy-101414-020426
Scott L.J. Brexanolone: First Global Approval. Drugs. 2019;79(7):779–783. doi: 10.1007/s40265-019-01121-0..
DOI: 10.1007/s40265-019-01121-0
Kanes S.J., Colquhoun H., Doherty J., Raines S., Hoffmann E., Rubinow D.R., Meltzer-Brody S. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression. Hum Psychopharmacol. 2017;32(2):e2576. doi: 10.1002/hup.2576..
DOI: 10.1002/hup.2576
Kanes S., Colquhoun H., Gunduz-Bruce H., Raines S., Arnold R., Schacterle A. et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017;390(10093):480–489. doi: 10.1016/S0140-6736(17)31264-3..
DOI: 10.1016/S0140-6736(17)31264-3
Meltzer-Brody S., Colquhoun H., Riesenberg R., Epperson C.N., Deligiannidis K.M., Rubinow D.R. et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–1070. doi: 10.1016/S0140-6736(18)31551-4..
DOI: 10.1016/S0140-6736(18)31551-4
Frieder A., Fersh M., Hainline R., Deligiannidis K.M. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development. CNS Drugs. 2019;33(3):265–282. doi: 10.1007/s40263-019-00605-7..
DOI: 10.1007/s40263-019-00605-7
Li Y.F. A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery. Pharmacol Ther. 2020;208:107494. doi: 10.1016/j.pharmthera.2020.107494..
DOI: 10.1016/j.pharmthera.2020.107494